Decibel Therapeutics Price Prediction
| DBTXDelisted Stock | USD 3.08 0.02 0.65% |
Oversold Vs Overbought
32
Oversold | Overbought |
Using Decibel Therapeutics hype-based prediction, you can estimate the value of Decibel Therapeutics from the perspective of Decibel Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Decibel Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Decibel because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Decibel Therapeutics after-hype prediction price | USD 3.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Decibel |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Decibel Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Decibel Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Decibel Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Decibel Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Decibel Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Decibel Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Decibel Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Decibel Therapeutics' historical news coverage. Decibel Therapeutics' after-hype downside and upside margins for the prediction period are 3.08 and 3.08, respectively. We have considered Decibel Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Decibel Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Decibel Therapeutics is based on 3 months time horizon.
Decibel Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Decibel Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Decibel Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Decibel Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 1 Events / Month | 11 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.08 | 3.08 | 0.00 |
|
Decibel Therapeutics Hype Timeline
Decibel Therapeutics is currently traded for 3.08. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Decibel is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Decibel Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 3.08. About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.67. Some equities with similar Price to Book (P/B) outperform the market in the long run. Decibel Therapeutics recorded a loss per share of 2.56. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be very soon. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.Decibel Therapeutics Related Hype Analysis
Having access to credible news sources related to Decibel Therapeutics' direct competition is more important than ever and may enhance your ability to predict Decibel Therapeutics' future price movements. Getting to know how Decibel Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Decibel Therapeutics may potentially react to the hype associated with one of its peers.
Decibel Therapeutics Additional Predictive Modules
Most predictive techniques to examine Decibel price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Decibel using various technical indicators. When you analyze Decibel charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Decibel Therapeutics Predictive Indicators
The successful prediction of Decibel Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Decibel Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Decibel Therapeutics based on analysis of Decibel Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Decibel Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Decibel Therapeutics's related companies.
Story Coverage note for Decibel Therapeutics
The number of cover stories for Decibel Therapeutics depends on current market conditions and Decibel Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Decibel Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Decibel Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Decibel Therapeutics Short Properties
Decibel Therapeutics' future price predictability will typically decrease when Decibel Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Decibel Therapeutics often depends not only on the future outlook of the potential Decibel Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Decibel Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 25 M | |
| Cash And Short Term Investments | 104.6 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Decibel Stock
If you are still planning to invest in Decibel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Decibel Therapeutics' history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |